Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BeOne Medicines Ltd. Director's Dealing 2022

Jun 24, 2022

30073_dirs_2022-06-24_641bee95-f0ba-4446-aa7b-4a2876214e9d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2022-06-22

Reporting Person: Wang Xiaodong (Director, Chair, Scientific Advisory Brd)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-22 Ordinary Shares A 83499 Acquired 5806746 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-06-22 Share Option (Right to Buy) $11.98 A 471913 Acquired 2032-06-21 Ordinary Shares (471913.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 1127542 Indirect
Ordinary Shares 172372 Indirect
Ordinary Shares 4253998 Indirect
Ordinary Shares 50 Indirect

Footnotes

F1: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service.

F2: These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

F3: These securities are held in a UTMA account for the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.

F4: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.

F5: These securities are held by the spouse of the Reporting Person.

F6: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F7: These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.